Your browser doesn't support javascript.
loading
Reevaluating the FDA's warning against the use of probiotics in preterm neonates: A societal statement by ESPGHAN and EFCNI.
van den Akker, Chris H P; Embleton, Nicholas D; Lapillonne, Alexandre; Mihatsch, Walter A; Salvatore, Silva; Canani, Roberto B; Dinleyici, Ener C; Domellöf, Magnus; Guarino, Alfredo; Gutiérrez-Castrellón, Pedro; Hojsak, Iva; Indrio, Flavia; Mosca, Alexis; Orel, Rok; van Goudoever, Johannes Hans B; Weizman, Zvi; Mader, Silke; Zimmermann, Luc J I; Shamir, Raanan; Vandenplas, Yvan; Szajewska, Hania.
Afiliação
  • van den Akker CHP; Department of Pediatrics-Neonatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Embleton ND; Amsterdam Reproduction and Development, and Amsterdam Gastroenterology Endocrinology Metabolism Research Institutes, Amsterdam, The Netherlands.
  • Lapillonne A; Neonatal Unit, Royal Victoria Infirmary, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Mihatsch WA; Department of Neonatology, APHP Necker University Hospital, Paris Cite University, Paris, France.
  • Salvatore S; Department of Pediatrics, Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, USA.
  • Canani RB; Department of Pediatrics, Ulm University, Ulm, Germany.
  • Dinleyici EC; Department of Health Management, Neu-Ulm University of Applied Sciences, Neu-Ulm, Germany.
  • Domellöf M; Department of Pediatrics, Zollernalb Klinikum, Balingen, Germany.
  • Guarino A; Department of Medicine and Technological Innovation, Pediatrics, Hospital "F. Del Ponte", University of Insubria, Varese, Italy.
  • Gutiérrez-Castrellón P; Department of Translational Medical Science and the ImmunoNutritionLab at the Ceinge Research Center and Task Force on Microbiome Studies, University of Naples Federico II, Naples, Italy.
  • Hojsak I; Department of Pediatrics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Indrio F; Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
  • Mosca A; Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, Naples, Italy.
  • Orel R; International Scientific Council for Probiotics, A.C., Ciudad de México (CDMX), Mexico.
  • van Goudoever JHB; Department of Pediatrics, University of Zagreb Medical School, Children's Hospital Zagreb, Zagreb, Croatia.
  • Weizman Z; Department of Experimental Medicine, Pediatric Section, Medical School MedTech, University of Salento, Lecce, Italy.
  • Mader S; Department Pediatric Gastroenterology and Nutrition, Robert-Debré Hospital, APHP, Paris, France.
  • Zimmermann LJI; Department of Gastroenterology, Hepatology and Nutrition, University Medical Center Ljubljana, University Children's Hospital Ljubljana, Medical Faculty, University of Ljubljana, Ljubeljana, Slovenia.
  • Shamir R; Department of Pediatrics, Amsterdam UMC, Emma Children's Hospital, University of Amsterdam, Amsterdam, The Netherlands.
  • Vandenplas Y; Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.
  • Szajewska H; European Foundation for the Care of Newborn Infants (EFCNI), Munich, Germany.
J Pediatr Gastroenterol Nutr ; 78(6): 1403-1408, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38572770
ABSTRACT
The recent advisory issued by the United States Food and Drug Administration, cautioning against the routine administration of probiotics in preterm neonates, has sparked a lively debate within the scientific community. This commentary presents a perspective from members of the Special Interest Group on Gut Microbiota and Modifications within the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and other authors who contributed to the ESPGHAN position paper on probiotics for preterm infants, as well as representatives from the European Foundation for the Care of Newborn Infants. We advocate for a more nuanced and supportive approach to the use of certain probiotics in this vulnerable population, balancing the demonstrated benefits and risks.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Recém-Nascido Prematuro / Probióticos País/Região como assunto: America do norte / Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Recém-Nascido Prematuro / Probióticos País/Região como assunto: America do norte / Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda